...Alberto Guijosa; Luis Antonio Cabrera-Miranda; Ana Pamela Gómez-García; Rogelio Trejo Rosales; Wendy Muñoz-Montaño; Diana Flores; Nancy Reynoso-Noverón; Oscar Arrieta Introduction: Pleural mesothelioma (PM) is a rare and aggressive cancer where prognostic assessment is crucial. Traditional...

...Sualp Tansan; Salïh Emri; Toros Selçuk; Yener Koç; Paul Hesketh; Tim Heeren; Ronald P. McCaffrey; Yusuf İzzettin Barış From October 1990 to September 1991, 20 consecutive patients with histologically proven malignant pleural mesothelioma (MPM), secondary to environmental exposure to asbestos...

... Mesothelioma Esophageal Carcinoma Malignant Melanoma Oncology 25: 225-233(1971) Clinical Evaluation of 5- (3,3-Dimethyl-l-Triazeno) Imidazole-4Carboxamide in Malignant Melanoma and Other Neoplasms: Comparison of Twice-weekly and Daily Administration Schedules J. A. Gottlieb and A .A .S erpick Baltimore...

...Georgia Karpathiou; Evangelia Argiana; Anastassios Koutsopoulos; Marios E. Froudarakis We report the case of a 56-year-old patient with malignant pleural mesothelioma of epithelial type, who responded to second-line chemotherapy with lipoplatin plus gemcitabine. Diagnosis and staging of the disease...

...Masahiro Maeda; Okio Hino Mesothelioma is an aggressive tumor arising from the mesothelium, and is usually associated with previous exposure to asbestos. The incubation period of the tumor may be described as 30–40 years, and the prognosis is dismal. Recently, serum markers for the diagnosis...